Clinical Trials in Ohio

Showing 7541-7560 of 20,938 trials

QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab

NCT02384954

This is a Phase I/II, open-label, multi-center, competitive enrollment and dose escalation study of N-803 in patients with relapse/refractory indolent B cell non-Hodgkin lymphoma in conjunction with rituximab.

Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma

Altor BioScience43 participantsStarted Apr 2015

Minneapolis, Minnesota, United States • St Louis, Missouri, United States • Columbus, Ohio, United States +1 more locations

COMPLETEDPhase 432 miles

Trial of Andexanet Alfa in ICrH Patients Receiving an Oral FXa Inhibitor

NCT03661528

Randomized, controlled clinical trial evaluating the efficacy and safety of andexanet alfa versus usual care in patients with intracranial hemorrhage anticoagulated with a direct oral FXa anticoagulant

Acute Intracranial Hemorrhage

Alexion Pharmaceuticals, Inc.530 participantsStarted Jun 2019

Fort Lauderdale, Florida, United States • Augusta, Georgia, United States • Royal Oak, Michigan, United States +139 more locations

QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab

Trial of Andexanet Alfa in ICrH Patients Receiving an Oral FXa Inhibitor

Find Trials by Condition in Ohio

Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

Vestibular Implants Tested in Human Subjects

ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo

A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects

A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

Efficacy of Human Placental Graft in Diabetic Foot Ulcers

Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma